Literature DB >> 29536546

Noninvasive prenatal paternity testing using targeted massively parallel sequencing.

Ning- Qu1,2, Yifan Xie3,4, Haiyan Li5, Hao- Liang1,2, Shaobin Lin6, Erwen Huang1,2, Jun- Gao7, Fang- Chen3, Yanwei Shi1,2, Xueling Ou1,2.   

Abstract

BACKGROUND: Recent advances in massively parallel sequencing (MPS) technology have provided efficient methods for noninvasive prenatal paternity testing (NIPAT). However, a well-accepted protocol has not been established. The present study developed an MPS-based approach for NIPAT and compared the performance of two recently reported methods for MPS data interpretation. STUDY DESIGN AND METHODS: We selected 1795 unlinked polymorphic single-nucleotide polymorphisms (SNPs) and performed paternity analysis in 34 real parentage test cases with maternal plasma samples using the Illumina HiSeq platform. Sequencing data were interpreted by the straightforward counting method for the identification of paternal alleles and mathematical algorithms for paternity index (PI) calculation, respectively.
RESULTS: Based on the sequencing data from each family case, both of the two statistical approaches produced a significant separation between the biological father and 90 unrelated males (p < 0.0001) when sufficient effective loci were attained. Nevertheless, up to 30.82% of real paternal alleles were filtered by a predefined cutoff and resulted in insufficient effective loci, especially in plasma samples with low fetal fraction (approx. 90.60% were filtered). In contrast, the PI calculation model utilized all maternal homozygous SNPs as effective loci (approx. 40% of total SNPs) and successfully identified the correct biological father, with the log-transformed combined PI (Lg(CPI)) value varying from 68.23 to 158.01 in each family case.
CONCLUSION: Our study illustrates that the Bayesian approach represents the better choice in NIPAT data interpretation. Further, the adoption of more informative markers (e.g., tri-allelic SNPs, tetra-allelic SNPs, and micro-haplotypes) or deeper sequencing is recommended for the improvement of the testing efficiency.
© 2018 AABB.

Entities:  

Mesh:

Year:  2018        PMID: 29536546     DOI: 10.1111/trf.14577

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  6 in total

1.  Introduction of Noninvasive Prenatal Testing for Blood Group and Platelet Antigens from Cell-Free Plasma DNA Using Digital PCR.

Authors:  Marion Eryilmaz; Dennis Müller; Gabi Rink; Harald Klüter; Peter Bugert
Journal:  Transfus Med Hemother       Date:  2019-12-05       Impact factor: 3.747

2. 

Authors:  靖 周; 艳 王; 恩萍 徐
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-25

Review 3.  Research progress on application of microhaplotype in forensic genetics.

Authors:  Jing Zhou; Yan Wang; Enping Xu
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-25

4.  Evaluation of a Microhaplotype-Based Noninvasive Prenatal Test in Twin Gestations: Determination of Paternity, Zygosity, and Fetal Fraction.

Authors:  Zhaochen Bai; Hu Zhao; Shaobin Lin; Linhuan Huang; Zhiming He; Huan Wang; Xueling Ou
Journal:  Genes (Basel)       Date:  2020-12-27       Impact factor: 4.096

5.  Noninvasive Prenatal Paternity Testing with a Combination of Well-Established SNP and STR Markers Using Massively Parallel Sequencing.

Authors:  Xuefeng Shen; Ran Li; Haixia Li; Yu Gao; Hui Chen; Ning Qu; Dan Peng; Riga Wu; Hongyu Sun
Journal:  Genes (Basel)       Date:  2021-03-22       Impact factor: 4.096

6.  Noninvasive prenatal paternity testing by means of SNP-based targeted sequencing.

Authors:  Jacqueline Chor Wing Tam; Yee Man Chan; Shui Ying Tsang; Chung In Yau; Shuk Ying Yeung; Ka Ki Au; Chun Kin Chow
Journal:  Prenat Diagn       Date:  2020-02-20       Impact factor: 3.050

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.